Progress Toward Long-Term Survivors of Glioblastoma
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 94 (7) , 1278-1286
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Extent of Resection of Glioblastoma Revisited: Personalized Survival Modeling Facilitates More Accurate Survival Prediction and Supports a Maximum-Safe-Resection Approach to SurgeryJournal of Clinical Oncology, 2014
- Glioblastoma survival in the United States before and during the temozolomide eraJournal of Neuro-Oncology, 2011
- Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?Radiation Oncology, 2011
- Disparities in Access to Neuro-oncologic Care in the United StatesArchives of Surgery, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastomaNeuro-Oncology, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaNew England Journal of Medicine, 2005
- Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysisNeuro-Oncology, 2004
- A phase III study of radiation therapy plus carmustine with or without recombinant interferon-? in the treatment of patients with newly diagnosed high-grade gliomaCancer, 2001